State Street SPDR S&P Biotech ETF (XBI): ETF
ETF traded on ARCX under symbol XBI. Quoted in usd.
State Street SPDR S&P Biotech ETF
-1.38%$149.54
ARCX:XBIEquity
AUM $10.55B·YTD --·Yield --
ARCX:XBI$149.54-1.38%AUM $10.55BTop Holdings
17.6% of portfolio in top 10 holdings
Concentrated in Healthcare (99.3%)
Performance:
 | MRNA MODERNA INC | +9.88% | 1.16M | |
 | NTRA NATERA INC | +3.37% | 474.6K | |
 | BIIB BIOGEN INC | +10.18% | 744.0K | |
 | HALO HALOZYME THERAPEUTICS INC | +11.73% | 1.46M | |
 | UTHR UNITED THERAPEUTICS CORP | +20.04% | 309.4K | |
 | AMGN AMGEN INC | +8.17% | 400.7K | |
 | ABBV ABBVIE INC | +7.76% | 624.9K | |
 | EXEL EXELIXIS INC | +13.75% | 2.69M | |
 | GILD GILEAD SCIENCES INC | +3.09% | 1.08M | |
 | TWST TWIST BIOSCIENCE CORP | -11.72% | 1.25M | |
 | IOVA IOVANCE BIOTHERAPEUTICS INC | +38.27% | 11.94M | |
 | SYRE SPYRE THERAPEUTICS INC | +2.45% | 1.80M | |
 | VRTX VERTEX PHARMACEUTICALS INC | +1.47% | 300.9K | |
 | REGN REGENERON PHARMACEUTICALS | +0.40% | 194.1K | |
 | ALKS ALKERMES PLC | +3.56% | 3.45M | |
 | TGTX TG THERAPEUTICS INC | -3.27% | 2.87M | |
 | PTGX PROTAGONIST THERAPEUTICS INC | -0.19% | 1.08M | |
 | PTCT PTC THERAPEUTICS INC | -2.81% | 2.32M | |
 | INCY INCYTE CORP | -7.16% | 1.24M | |
 | NBIX NEUROCRINE BIOSCIENCES INC | +2.30% | 1.01M | |
 | KRYS KRYSTAL BIOTECH INC | -8.85% | 450.4K | |
 | CRSP CRISPR THERAPEUTICS AG | -11.42% | 2.88M | |
 | RVMD REVOLUTION MEDICINES INC | -1.97% | 755.0K | |
 | ROIV ROIVANT SCIENCES LTD | -0.90% | 3.75M | |
 | BBIO BRIDGEBIO PHARMA INC | +4.34% | 2.06M |
Institutional Holders
Sector Breakdown
| Sector | Weight |
|---|---|
| Healthcare | 99.28% |
| Financial Services | 0.72% |
Holdings Treemap
Country Allocation
| Country | Weight |
|---|---|
| United States | 95.15% |
| Ireland | 1.53% |
| Switzerland | 1.37% |
| United Kingdom | 1.34% |
| Netherlands | 0.47% |
| Other | 0.14% |